Matches in SemOpenAlex for { <https://semopenalex.org/work/W2555622037> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2555622037 abstract "Abstract We introduced a risk-adapted treatment program for non-APL AML in four Swedish health regions. The aim was to optimise treatment results by the use of risk group stratification, mainly based on cytogenetic findings at diagnosis. All patients received induction therapy with idarubicin-cytarabine 3+7 and consolidation cycles containing high-dose cytarabine. Stem cell transplantation was done in CR1 in selected patients, sparing patients with low/intermediate risk of relapse the risks associated with transplantation. 279 patients, 77% of all AML patients 18–60 years (median 51 yrs), in the population were included in the program. Cytogenetics was performed in 98%. Excluding APL, 19 patients had low-risk. The intermediate-risk group consisted of 165 patients, 96 with a normal karyotype. 95 patients were allocated to the high-risk group. 6% died < 30 days after diagnosis. CR rate was 80%. 111 transplants, 78 allogeneic/URD and 33 autologous, were performed in CR1. 40% of all patients were alive after five years. Median overall survival time was 887 days in low-risk, 611 days in intermediate risk, 345 days in high-risk patients. Relapse-free survival times were also significantly (p<0.001) different between the three risk groups. 43% of responding patients were alive in first remission after four years. 4-year relapse-free survival was significantly better for both intermediate risk (67%) and high-risk (41%) with allogeneic/URD transplantation than with autologous transplant or chemotherapy alone. Relapse was observed more often among patients treated with chemotherapy alone (42%, p=0.03) or with autologous transplants (42%, p=0.09) than among patients receiving allogeneic/URD transplants in CR1, 22%. Our results do not support the use of autologous transplantation in AML in first remission." @default.
- W2555622037 created "2016-11-30" @default.
- W2555622037 creator A5006337337 @default.
- W2555622037 creator A5011172454 @default.
- W2555622037 creator A5088708221 @default.
- W2555622037 date "2004-11-16" @default.
- W2555622037 modified "2023-09-29" @default.
- W2555622037 title "Application of Risk-Adapted Therapy for Acute Myeloid Leukemia to a Population. Effects of Stem Cell Transplantation on Outcome." @default.
- W2555622037 doi "https://doi.org/10.1182/blood.v104.11.4449.4449" @default.
- W2555622037 hasPublicationYear "2004" @default.
- W2555622037 type Work @default.
- W2555622037 sameAs 2555622037 @default.
- W2555622037 citedByCount "0" @default.
- W2555622037 crossrefType "journal-article" @default.
- W2555622037 hasAuthorship W2555622037A5006337337 @default.
- W2555622037 hasAuthorship W2555622037A5011172454 @default.
- W2555622037 hasAuthorship W2555622037A5088708221 @default.
- W2555622037 hasConcept C126322002 @default.
- W2555622037 hasConcept C141071460 @default.
- W2555622037 hasConcept C143998085 @default.
- W2555622037 hasConcept C2777408962 @default.
- W2555622037 hasConcept C2778041864 @default.
- W2555622037 hasConcept C2778461978 @default.
- W2555622037 hasConcept C2778729363 @default.
- W2555622037 hasConcept C2779050716 @default.
- W2555622037 hasConcept C2779117419 @default.
- W2555622037 hasConcept C2908647359 @default.
- W2555622037 hasConcept C2911091166 @default.
- W2555622037 hasConcept C71924100 @default.
- W2555622037 hasConcept C99454951 @default.
- W2555622037 hasConceptScore W2555622037C126322002 @default.
- W2555622037 hasConceptScore W2555622037C141071460 @default.
- W2555622037 hasConceptScore W2555622037C143998085 @default.
- W2555622037 hasConceptScore W2555622037C2777408962 @default.
- W2555622037 hasConceptScore W2555622037C2778041864 @default.
- W2555622037 hasConceptScore W2555622037C2778461978 @default.
- W2555622037 hasConceptScore W2555622037C2778729363 @default.
- W2555622037 hasConceptScore W2555622037C2779050716 @default.
- W2555622037 hasConceptScore W2555622037C2779117419 @default.
- W2555622037 hasConceptScore W2555622037C2908647359 @default.
- W2555622037 hasConceptScore W2555622037C2911091166 @default.
- W2555622037 hasConceptScore W2555622037C71924100 @default.
- W2555622037 hasConceptScore W2555622037C99454951 @default.
- W2555622037 hasLocation W25556220371 @default.
- W2555622037 hasOpenAccess W2555622037 @default.
- W2555622037 hasPrimaryLocation W25556220371 @default.
- W2555622037 hasRelatedWork W2090076603 @default.
- W2555622037 hasRelatedWork W2154047650 @default.
- W2555622037 hasRelatedWork W2281026269 @default.
- W2555622037 hasRelatedWork W2531501222 @default.
- W2555622037 hasRelatedWork W2541371606 @default.
- W2555622037 hasRelatedWork W2572240764 @default.
- W2555622037 hasRelatedWork W2578349514 @default.
- W2555622037 hasRelatedWork W2588299484 @default.
- W2555622037 hasRelatedWork W3002693768 @default.
- W2555622037 hasRelatedWork W4235813248 @default.
- W2555622037 isParatext "false" @default.
- W2555622037 isRetracted "false" @default.
- W2555622037 magId "2555622037" @default.
- W2555622037 workType "article" @default.